🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Phoenix
Start Date
2017-03-27
Trial ID
NCT03062540
Treatments Being Tested
This is a Phase 2, randomized, parallel-group, double-blind, placebo-contro...
Status
Completed
Location
Accel Research-Birmingham Clinical Research Unit
Start Date
2022-08-18
Trial ID
NCT05472090
Treatments Being Tested
Evaluate the long-term safety of TNX-102 SL 5.6 mg taken daily at bedtime o...
Status
Completed
Location
Little Rock
Start Date
2018-04-19
Trial ID
NCT03508700
Treatments Being Tested
This is a Phase 3, randomized, parallel-group, double-blind, placebo-contro...
Status
Completed
Location
Tonix Clinical Site
Start Date
2020-07-22
Trial ID
NCT04508621
Treatments Being Tested
Primary Objectives: To characterize the pharmacokinetic (PK) profile and do...
Status
Completed
Location
Altasciences Clinical Los Angeles, Inc.
Start Date
2022-03-18
Trial ID
NCT07464535
Treatments Being Tested
This will be a single center, comparative pharmacokinetic, open-label, rand...
Status
Completed
Location
Quebec City
Start Date
2018-01-29
Trial ID
NCT03443960
Treatments Being Tested
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Completed
Location
Tuscaloosa VA Medical Center
Start Date
2014-10
Trial ID
NCT02277704
Treatments Being Tested
This is a Phase 3, randomized, parallel-group, double-blind, placebo-contro...
Status
Completed
Location
Tonix Clinical Site
Start Date
2019-12-09
Trial ID
NCT04172831
Treatments Being Tested
The goal of this clinical trial is to learn if a drug called TNX-102 SL wor...
Status
Recruiting
Location
IMA Clinical Research- Phoenix
Start Date
2026-06
Trial ID
NCT07621237
Treatments Being Tested
This is a Phase 3, randomized, parallel-group, double-blind, placebo-contro...
Status
Completed
Location
Tonix Clinical Site
Start Date
2022-04-06
Trial ID
NCT05273749
Treatments Being Tested